$18.9 Bn Cell-based Assay (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services) Market – Global Forecast to 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell-based
Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits,
Instruments, Services), Application (Drug Discovery, Research), End User
(CROs, Biopharma Companies, Research Institutes), Geography – Global
Forecast to 2024” report has been added to ResearchAndMarkets.com’s
offering.

The cell-based assays market is projected to reach USD 18.9 billion by
2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during the
forecast period.

Growth in this market is mainly driven by the increasing research
funding, and the growth in the number of drug discovery activities.
Emerging economies with growing R&D expenditures are also expected to
provide opportunities for the growth of the market.

Services exhibited the highest CAGR over the forecast period.

By product & service, the cell-based assays market is segmented into
consumables, instruments and services. Over the forecast period, the
services segment accounted for the highest CAGR. The increased R&D
investments and technological innovations in supportive processes such
as high-throughput screening is driving the growth of this product &
service segment.

Basic research held the significant share in the cell-based
assays market in 2019

On the basis of application, the cell-based assays market is segmented
into drug discovery, basic research and other research such as quality
check among others. In 2019, the drug discovery segment accounted for
the largest share of the cell-based assays market. The large share of
this segment can be attributed to the rising adoption of in vitro
testing over animal testing and increasing in R&D spending by
biopharmaceutical companies.

Asia Pacific exhibited the highest CAGR over the forecast
period

North America, which includes the US and Canada, accounted for the
largest share of the cell-based assays market. The large share of this
market segment can be attributed to the increasing drug discovery
activities by pharmaceutical and biotechnology companies. In addition to
this, consolidations between academic and government institutes with
biopharmaceutical companies in the region are also driving the growth of
this market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Cell-Based Assays: Market Overview

4.2 Cell-Based Assays Market, By Product & Service and Application (2018)

4.3 Geographical Snapshot of the Cell-Based Assays Market

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.1.1 Growing Preference for Cell-Based Assays

5.2.1.2 Growing Research Funding

5.2.1.3 Growth in the Number of Drug Discovery Activities

5.2.2 Restraint

5.2.2.1 High Cost of Instruments and Restrictions on Reagent Use

5.2.3 Opportunities

5.2.3.1 High-Growth Asian Countries

5.2.3.2 Application of Novel Cell-Based Assays in Cancer Research

6 Cell-Based Assays Market, By Product & Service

6.1 Introduction

6.2 Consumables

6.2.1 Reagents

6.2.1.1 Reagents Have Widespread Usage in Life Sciences Due to Their
Application in Immunology Research, Disease Research, and Cancer
Diagnostics

6.2.2 Assay Kits

6.2.2.1 Reporter Gene Assays

6.2.2.1.1 Reporter Gene Assays Can Be Used With Limited Resources for
the Establishment of Hts Platforms, Presenting Opportunities for Small
Laboratories With Limited Resources

6.2.2.2 Second Messenger Assays

6.2.2.2.1 Second Messenger Assays Allow the Detection and
Characterization of All Compound Classes – A Key Driver for Market Growth

6.2.2.3 Cell Growth Assays

6.2.2.3.1 Cell Viability and Cell Proliferation Assays are the Two Most
Important in Vitro Quantification Techniques for Assessing Cell Growth

6.2.2.4 Cell Death Assays

6.2.2.4.1 Cell Death Quantification is Essential in Drug Development to
Identify the Manner in Which Potential Drugs Could Inhibit Or Enhance
Molecular Targets – A Key Factor Propelling Market Demand

6.2.2.5 Other Assay Kits

6.2.3 Probes & Labels

6.2.3.1 Effective Labeling of Cells Helps in Studying Cellular Events in
A Spatial and Temporal Context – A Key Factor Driving the Demand for
Probes and Labels

6.2.4 Microplates

6.2.4.1 Increasing Demand for Cell-Based Assays in Drug Discovery, Basic
Research, and Preclinical Safety Studies is Encouraging the Consumption
of Microplates

6.2.5 Cell Lines

6.2.5.1 Immortalized Cell Lines

6.2.5.1.1 Advantages of Immortalized Cell Lines Creating A Demand for
These Cell Lines Over Primary and Stem Cell Lines

6.2.5.2 Primary Cell Lines

6.2.5.2.1 Primary Cell Lines are More Sensitive as Compared to
Immortalized Cell Lines – A Key Factor Limiting Market Growth

6.2.5.3 Stem Cell Lines

6.2.5.3.1 Stem Cell Lines are Alternative Methodologies to Address the
Cellularity Issues That Involve the Directed Differentiation of
Embryonic Stem (Es) Cells Or Induced Pluripotent Stem Cells (Ips)

6.2.6 Other Consumables

6.3 Instruments

6.3.1 Biotechnology Companies Aim to Streamline Their Workflows to
Improve Productivity and Reduce Costs, Which Will Drive the Growth of
the Instruments Market

6.4 Services

7 Cell-Based Assays Market, By Application

7.1 Introduction

7.2 Drug Discovery

7.2.1 Toxicity Studies

7.2.1.1 Increasing Adoption of High-Content Screening for Evaluating
Cytotoxicity is A Factor Stimulating the Use of Cell-Based Assays for
Toxicity Studies

7.2.2 Pharmacokinetic Studies

7.2.2.1 Demand for Adme Studies to Rise Due to the Growing Need for
Improved Clinical Success – A Major Factor Driving Growth

7.2.3 Pharmacodynamic Studies

7.2.3.1 Increasing Number of Pharmacodynamics Studies Globally to Drive
Growth in the Cell-Based Assays Market

7.3 Basic Research

7.3.1 Increasing Funding By Government Institutes for Basic Research to
Drive the Demand for Cell-Based Assay Products & Services

7.4 Other Applications

8 Cell-Based Assays Market, By End User

8.1 Introduction

8.2 Pharmaceutical & Biotechnology Companies

8.2.1 The Demand for Cell-Based Assays in This End-User Segment is
Primarily Driven By the Growth in the Number of R&D Activities

8.3 Academic & Government Institutes

8.3.1 Increasing Interest of Academic Institutions to Develop Assays for
Innovative Applications to Drive the Demand for Cell-Based Assays in
This End-User Segment

8.4 Contract Research Organizations

8.4.1 Growth in Outsourcing to Drive the Demand for Cell-Based Assays in
Contract Research Organizations

9 Cell-Based Assays Market, By Region

9.1 Introduction

9.2 North America

9.2.1 US

9.2.2 Canada

9.3 Europe

9.3.1 UK

9.3.2 Germany

9.3.3 France

9.3.4 Rest of Europe

9.4 Asia Pacific

9.4.1 China

9.4.2 Japan

9.4.3 India

9.4.4 Rest of Asia Pacific

9.5 Rest of the World

10 Competitive Landscape

10.1 Overview

10.2 Market Ranking Analysis, 2017

10.3 Key Strategies

10.4 Competitive Leadership Mapping (2017)

10.5 Visionary Leaders

10.6 Innovators

10.7 Competitive Leadership Mapping for Start-Ups (2017)

11 Company Profiles

11.1 Thermo Fisher Scientific Inc.

11.2 Danaher Corporation

11.3 Becton, Dickinson and Company

11.4 Ge Healthcare

11.5 Merck KGaA

11.6 Lonza Group Ltd.

11.7 Perkinelmer, Inc.

11.8 Charles River Laboratories, Inc.

11.9 Cell Signaling Technology, Inc.

11.10 Promega Corporation

11.11 Cisbio

11.12 Cell Biolabs, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/fbxnx7

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology